国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
17期
2130-2134
,共5页
李伟%龙晚生%罗学毛%陈曼琼%兰勇%何义改
李偉%龍晚生%囉學毛%陳曼瓊%蘭勇%何義改
리위%룡만생%라학모%진만경%란용%하의개
精神分裂症%磁共振%氢质子波谱
精神分裂癥%磁共振%氫質子波譜
정신분렬증%자공진%경질자파보
Schizophrenia%Magnetic resonance%Proton magnetic resonance spectroscopy
目的 探讨质子磁共振波谱( 1H-MRS)在精神分裂症中的诊断价值。方法 采用点分辨解析采样方式对26例精神分裂症患者和25例健康志愿者的左右侧额叶、海马和丘脑行MRS检查,分析的代谢产物有N-乙酰天门冬氨酸(NAA)、肌酸(Cr)、胆碱(Cho)及相互间比值在两组间的差别。结果 精神分裂症患者在左额叶、右额叶、左海马、右海马、左丘脑和右丘脑的NAA/Cr分别为1.41±0.33、1.40±0.36、1.43±0.27、1.42±0.26、1.46±0.30、1.45±0.28,低于健康组对应位置,但差异无统计学意义(P>0.05);Cho/Cr分别为1.36±0.38、1.37±0.29、1.30±0.31、1.31±0.28、1.20±0.20、1.22±0.19,高于健康组对应位置,但差异无统计学意义(P> 0.05);NAA/( Cho+Cr)分别为0.60±0.14、0.61±0.16、0.62±0.20、0.63±0.23、0.66±0.18、0.66±0.21,明显低于健康组对应位置,且二组差异有统计学意义(P< 0.05)。精神分裂症患者NAA/Cr、NAA/( Cho+Cr)的下降幅度和Cho/Cr的上升幅度,额叶>海马>丘脑。结论 精神分裂症患者MRS改变,主要体现在NAA的下降和Cho的上升,对精神分裂症的诊断有一定的参考作用。
目的 探討質子磁共振波譜( 1H-MRS)在精神分裂癥中的診斷價值。方法 採用點分辨解析採樣方式對26例精神分裂癥患者和25例健康誌願者的左右側額葉、海馬和丘腦行MRS檢查,分析的代謝產物有N-乙酰天門鼕氨痠(NAA)、肌痠(Cr)、膽堿(Cho)及相互間比值在兩組間的差彆。結果 精神分裂癥患者在左額葉、右額葉、左海馬、右海馬、左丘腦和右丘腦的NAA/Cr分彆為1.41±0.33、1.40±0.36、1.43±0.27、1.42±0.26、1.46±0.30、1.45±0.28,低于健康組對應位置,但差異無統計學意義(P>0.05);Cho/Cr分彆為1.36±0.38、1.37±0.29、1.30±0.31、1.31±0.28、1.20±0.20、1.22±0.19,高于健康組對應位置,但差異無統計學意義(P> 0.05);NAA/( Cho+Cr)分彆為0.60±0.14、0.61±0.16、0.62±0.20、0.63±0.23、0.66±0.18、0.66±0.21,明顯低于健康組對應位置,且二組差異有統計學意義(P< 0.05)。精神分裂癥患者NAA/Cr、NAA/( Cho+Cr)的下降幅度和Cho/Cr的上升幅度,額葉>海馬>丘腦。結論 精神分裂癥患者MRS改變,主要體現在NAA的下降和Cho的上升,對精神分裂癥的診斷有一定的參攷作用。
목적 탐토질자자공진파보( 1H-MRS)재정신분렬증중적진단개치。방법 채용점분변해석채양방식대26례정신분렬증환자화25례건강지원자적좌우측액협、해마화구뇌행MRS검사,분석적대사산물유N-을선천문동안산(NAA)、기산(Cr)、담감(Cho)급상호간비치재량조간적차별。결과 정신분렬증환자재좌액협、우액협、좌해마、우해마、좌구뇌화우구뇌적NAA/Cr분별위1.41±0.33、1.40±0.36、1.43±0.27、1.42±0.26、1.46±0.30、1.45±0.28,저우건강조대응위치,단차이무통계학의의(P>0.05);Cho/Cr분별위1.36±0.38、1.37±0.29、1.30±0.31、1.31±0.28、1.20±0.20、1.22±0.19,고우건강조대응위치,단차이무통계학의의(P> 0.05);NAA/( Cho+Cr)분별위0.60±0.14、0.61±0.16、0.62±0.20、0.63±0.23、0.66±0.18、0.66±0.21,명현저우건강조대응위치,차이조차이유통계학의의(P< 0.05)。정신분렬증환자NAA/Cr、NAA/( Cho+Cr)적하강폭도화Cho/Cr적상승폭도,액협>해마>구뇌。결론 정신분렬증환자MRS개변,주요체현재NAA적하강화Cho적상승,대정신분렬증적진단유일정적삼고작용。
0bjective To explore the diagnostic value of proton magnetic resonance spectroscopy ( 1H-MRS ) in schizophrenia. Methods Using point resolved acquisition mode, 26 schizophrenia patients and 25 healthy subjects underwent MRS examination nn the left and right frontal, hippocampus and thalamus. The metabolites of MRS including N-acetyl aspartate ( NAA ), creatine ( Cr ), and chohne ( Cho ) were analyzed and compared between the two groups. Results NAA/Cr in the left and right frontal, hippocampus, and thalamus was 1.41 ± 0.33, 1.40 ± 0.36, 1.43 ± 0.27, 1.42 ± 0.26,1.46 ± 0.30, and 1.45 ± 0.28, respectively in schizophrenia patients, which was lower than those in the healthy subjects, but with no significant difference ( P> 0.05 ), Cho/Cr was 1.36 ± 0.38, 1.37 ± 0.29,1.30 ± 0.31, 1.31 ± 0.28, 1.20 ± 0.20, and 1.22 ± 0.19, respectively, which was higher than those in the healthy subjects, whereas with no significant difference ( P> 0.05 ), NAA/( Cho+Cr ) was 0.60 ± 0.14, 0.61 ± 0.16, 0.62 ± 0.20, 0.63 ± 0.23, 0.66 ± 0.18, and 0.66 ± 0.21, respectively, which was lower than those in healthy subjects, with a significant difference ( P < 0.05 ). In schizophrenia patients, the levels of NAA/Cr, NAA/( Cho+Cr ) decreased and Cho/Cr increased in the order of frontal to hippocampus and then to thalamus. Conclusions A decline in NAA and a rise in Cho are the main demonstration on MRS for schizophrenia patients, which plays a role in the diagnosis of schizophrenia.